CA1 Discordant Diagnoses in Sarcoma, GIST and Desmoide Tumour in France: Results From the Network RREPS

Value in Health - United Kingdom
doi 10.1016/j.jval.2012.08.518
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Serum Tumour Markers: Implications of Discordant Results

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
1994English

Malignant Gastrointestinal Stromal Cell Tumour (GIST) of the Stomach

South African Journal of Radiology
RadiologicalRadiologyNuclear MedicineUltrasound TechnologyImaging
2002English

Incidence and Time Trends of Sarcoma (2000–2013): Results From the French Network of Cancer Registries (FRANCIM)

BMC Cancer
Cancer ResearchOncologyGenetics
2020English

Validity of Ankylosing Spondylitis Diagnoses in the Health Improvement Network

Pharmacoepidemiology and Drug Safety
EpidemiologyPharmacology
2016English

Relevance of Reference Centers in Sarcoma Care and Quality Item Evaluation: Results From the Prospective Registry of the Spanish Group for Research in Sarcoma (GEIS)

Oncologist
Cancer ResearchMedicineOncology
2018English

Age-Related Sarcoma Patient Experience: Results From a National Survey in England

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Discordant Results in Tc-99m Tetrofosmin and Tc-99m Sestamibi Parathyroid Scintigraphies

Arquivos Brasileiros de Endocrinologia & Metabologia
2007English

Ac3 - Discordant Designations of Breakthrough Drug Innovation: France Versus the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

The Hazards of Asbestos. Inaccurate Diagnoses Distort Results.

BMJ
1993English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy